Relapse After Cessation of Immunosuppressants in Seropositive Neuromyelitis Optica Spectrum Disorder With Long-Term Remission

참고문헌 (9)

1. Wingerchuk DM, "A secondary progressive clinical course is uncommon in neuromyelitis optica", Neurology, 68, pp.603~605 (2007)
2. Trebst C, "Update on the diagnosis and treatment of neuromyelitis optica : recommendations of the Neuromyelitis Optica Study Group(NEMOS)", J Neurol, 261, pp.1~16 (2014)
3. Wingerchuk DM, "International consensus diagnostic criteria for neuromyelitis optica spectrum disorders", Neurology, 85, pp.177~189 (2015)
4. Kim SH, "Discontinuation of immunosuppressive therapy in patients with neuromyelitis optica spectrum disorder with aquaporin-4 antibodies", Neurol Neuroimmunol Neuroinflamm, 8, pp.e947~ (2021)
5. Seok JM, "Clinical characteristics of disabling attacks at onset in patients with neuromyelitis optica spectrum disorder", J Neurol Sci, 368, pp.209~213 (2016)
6. Akaishi T, "Neuromyelitis optica spectrum disorders with unevenly clustered attack occurrence", Neurol Neuroimmunol Neuroinflamm, 7, pp.e640~ (2019)
7. Pandit L, "Spontaneous remission lasting more than a decade in untreated AQP4 antibody-positive NMOSD", Neurol Neuroimmunol Neuroinflamm, 4, pp.e351~ (2017)
8. Watanabe M, "Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD", Neurology, 93, pp.e1299~ (2019)
9. Mealy MA, "Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders", Mult Scler, 24, pp.1737~1742 (2018)

관련 논문AI추천